NUMAB
Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases such as chronic inflammation and cancer. It features a plug-and-play platform that substantially reduces the random nature of the discovery process to predictably yield ready-to-develop multispecific biotherapeutics.
NUMAB
Industry:
Biopharma Biotechnology Health Care Health Diagnostics Life Science Medical Therapeutics
Founded:
2011-01-01
Address:
Wadenswil, Zurich, Switzerland
Country:
Switzerland
Website Url:
http://www.numab.com
Total Employee:
11+
Status:
Active
Contact:
41445330471
Email Addresses:
[email protected]
Total Funding:
122 M CHF
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Google Universal Analytics
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
ARNA Genomics
ARNA Genomics is a biotechnology company that specializes in developing fluid biopsy technology.
Beta Bugs
Beta Bugs is a cutting edge biotechnology company that produces enhanced insect strains for the growing insect farming industry.
Biomnigene
Biomnigene is a biotechnology agency that offers DNA/RNA extraction to microbiome analysis and research services.
Demetrix
Demetrix is a biotechnology company dedicated to researching and producing bioactive ingredients.
Genomics
Genomics plc aiming to lead the genomic transformation of healthcare.
Imago BioSciences
Imago is a clinical stage biopharmaceutical company discovering new medicines for the treatment of myeloproliferative neoplasms (MPNs).
Libre Foods
Libre Foods is a biotech startup on a mission to liberate the food system and create a more free future for people, the planet and animals.
Oxitec
Oxitec develops an environment-friendly technology for the control of significant insect pests to prevent diseases and agricultural damage.
Current Advisors List
Current Employees Featured
Founder
Investors List
Cormorant Asset Management
Cormorant Asset Management investment in Series C - Numab
HBM Partners
HBM Partners investment in Series C - Numab
BlackRock
BlackRock investment in Series C - Numab
Forbion Capital Partners
Forbion Capital Partners investment in Series C - Numab
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Series C - Numab
RTW Investments LLC
RTW Investments LLC investment in Series C - Numab
BVF Partners
BVF Partners investment in Series C - Numab
Novo Holdings
Novo Holdings investment in Series C - Numab
Octagon Capital Advisors
Octagon Capital Advisors investment in Series C - Numab
3sbio
3sbio investment in Series B - Numab
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2019-12-12 | 3sbio | Numab investment in Post-IPO Equity - 3sbio | 15 M CHF |
Official Site Inspections
http://www.numab.com Semrush global rank: 8.83 M Semrush visits lastest month: 245
- Host name: 212.243.197.113
- IP address: 212.243.197.113
- Location: Onex Switzerland
- Latitude: 46.1877
- Longitude: 6.0981
- Timezone: Europe/Zurich
- Postal: 1213
